Related Experiment Video
Updated: May 20, 2026

Oxygenation-sensitive Cardiac MRI with Vasoactive Breathing Maneuvers for the Non-invasive Assessment of Coronary Microvascular Dysfunction
Published on: August 17, 2022
Coronary microvascular function in patients with Cushing's syndrome
Francesco Fallo1, Giulia Famoso, Dario Capizzi
1Department of Medicine, University of Padova, Via Giustiniani 2, 35128, Padua, Italy. francesco.fallo@unipd.it
Insights
Coronary microvascular function is reduced in Cushing's syndrome patients, even without heart disease symptoms. This early coronary abnormality may be linked to comorbidities and potentially urinary cortisol levels.
Area of Science:
- Cardiology
- Endocrinology
- Vascular Biology
Background:
- Cushing's syndrome (CS) is characterized by prolonged exposure to excess cortisol, leading to cardiovascular complications.
- Coronary microvascular dysfunction is an early indicator of cardiovascular disease, but its prevalence in CS is not well-established.
- Assessing coronary flow reserve (CFR) provides insight into microvascular function.
Purpose of the Study:
- To evaluate coronary flow reserve (CFR) in patients with newly diagnosed Cushing's syndrome.
- To determine if CS is associated with impaired coronary microvascular function.
- To explore the relationship between urinary cortisol levels and CFR in CS patients.
Main Methods:
- Transthoracic Doppler echocardiography was used to measure coronary flow velocity at rest and during adenosine-induced hyperemia.
- Coronary flow reserve (CFR) was calculated as the ratio of hyperemic to resting diastolic flow velocity.
- Multi-slice computed tomographic coronary angiography excluded epicardial coronary stenosis in patients with reduced CFR.
Main Results:
- A reduced CFR (≤ 2.5) was observed in 33% of CS patients and 27% of controls.
- No epicardial coronary artery disease was detected in CS patients with abnormal CFR.
- CFR was inversely correlated with urinary cortisol levels in CS patients (Spearman's rho = -0.57, P = 0.03).
Conclusions:
- Coronary microvascular function is pathologically reduced in a significant number of CS patients, independent of epicardial coronary artery lesions.
- Comorbidities may contribute to early coronary abnormalities in both CS patients and matched controls.
- Further research is needed to confirm urinary cortisol as a predictor of coronary microvascular function in Cushing's syndrome.
Abstract:
The aim of the study was to evaluate patients with Cushing's syndrome the coronary flow reserve (CFR), an index of coronary microvascular function. Fifteen newly diagnosed patients with Cushing's syndrome (1 male/14 females; mean age 45 ± 11 years), were selected for having no clinical evidence of ischemic heart disease. Twelve patients had pituitary-dependent Cushing's disease and three had an adrenal adenoma. Fifteen subjects matched for age, sex, and major cardiovascular risk factors were used as controls. Coronary flow velocity in the left anterior descending coronary artery was investigated by transthoracic Doppler echocardiography at rest and during adenosine infusion. CFR was obtained as the ratio hyperemic/resting diastolic flow velocity. A reduced coronary reserve (hyperemic/resting ratio ≤ 2.5) was found in 5/15 Cushing patients and 4/15 controls. In all patients with abnormal CFR, epicardial coronary stenosis was excluded by multi-slice computed tomographic coronary angiography. CFR was inversely related to urinary cortisol in patients with endogenous hypercortisolism (Spearman's rho = -0.57, P = 0.03), while no correlation was found in controls. Coronary microvascular function, as assessed by CFR, is pathologically reduced in a considerable number of patients with Cushing's syndrome without clinical symptoms of ischemic heart disease and in the absence of epicardial coronary artery lesions, as well as in controls matched for cardiovascular risk factors. The presence of comorbidities can explain this early coronary abnormality in both patients and controls. Whether urinary cortisol may be a predictor of coronary microvascular function in the setting of patients with Cushing's syndrome, needs further investigation.
Related Concept Videos
Cushing Syndrome II: Pathophysiology
Cushing Syndrome I: Introduction
Coronary Artery Disease II: Pathophysiology
Coronary Artery Disease III: Clinical Manifestations
Acute Coronary Syndrome III: Diagnostic Studies
Coronary Artery Disease I: Introduction
